Regulation & Policy Market Research Reports & Industry Analysis
In the United States drugs, diagnostics and medical devices are regulated by the Food and Drug Administration (FDA). The FDA is an agency of the United States Department of Health and Human Services, one of the United States federal executive departments. The FDA is responsible for protecting and promoting public health through the regulation and supervision of food safety, tobacco products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), veterinary products, and cosmetics.
The FDA derives its power from the Food, Drug and Cosmetic Act,[7] (Passed in 1938 and amended since) and are codified in Title 21, Chapter 9 of the United States Code. Some other laws that impact the FDA’s authority is Public Health Service Act, parts of the Controlled Substances Act, the Federal Anti-Tampering Act.
Regulation & Policy Industry Research & Market Reports
-
The 2025-2030 World Outlook for Pharmacovigilance Technologies
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Orphan Drugs
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for GxP-GMP Regulation Testing Services
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Post-Marketing Pharmacovigilance and Medical Information
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow ... Read More
-
The 2025-2030 World Outlook for Validation, Calibration and Standardization in the Global Life Sciences
... For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, ... Read More
-
The 2025-2030 World Outlook for Counterfeit Drug Detection Devices
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
Global Botanical and Plant-Derived Drugs Market 2024-2028
... on the botanical and plant-derived drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an up-to-date analysis ... Read More
-
Orphan Drugs Global Market Report 2024
... Distribution Channel: Hospital Pharmacy; Retail Pharmacy; Online Sales Covering: Pfizer Inc.; Johnson & Johnson Services Inc.; F Hoffmann-La Roche Ltd.; Farbenfabriken Bayer AG; Novartis AG Orphan Drugs Global Market Report 2024 from The Business Research ... Read More
-
Pharma Wholesale and Distribution Market Report 2024-2034
... industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region. Increasing Government Initiatives for Pharmaceutical Products ... Read More
-
Global Pharmaceutical Testing Market Professional Survey by Types, Applications, and Players, with Regional Growth Rate Analysis and Development Situation, from 2023 to 2028
... of the Pharmaceutical Testing industry between the year 2018 to 2028, and breaks down according to the product type, downstream application, and consumption area of Pharmaceutical Testing. The report also introduces players in the industry ... Read More
-
Pharmacovigilance Global Market Report 2024
... Management; Signal Detection; Risk Management System 4) By Clinical Trial Phases: Preclinical; Phase I; Phase II; Phase III; Phase IV 5) By End User: Hospitals; Pharmaceutical Companies Covering: IQVIA; Cognizant; ICON Plc; Accenture plc; PAREXEL ... Read More
-
Real World Evidence Solutions Market by Component (Services, Disparate Data Sets (Clinical), Application (Drug and Medical Device Development and Approvals), Mode of Deployment, Revenue Model, End Users, & Region, Business Model - Global Forecast to 2029
... 2029 The global Real-World Evidence Solutions market is projected treach USD 4.5 Billion by 2029 from USD 2.0 billion in 2024, at a CAGR of 16.5% from 2024 t2029. The growth of the market is ... Read More
-
Australia and New Zealand Endotoxin Testing Market Report and Forecast 2024-2032
... endotoxin testing market size is anticipated to grow at a CAGR of 9.5% during the forecast period of 2024-2032, driven by the increase in development of innovative, rapid, and sensitive testing methods. Endotoxin Testing: Introduction ... Read More
-
Pharmaceuticals Markets in China
... high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, ... Read More
-
GMP Testing Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)
... 2 billion by 2029, growing at a CAGR of 6.84% during the forecast period (2024-2029). Lockdowns were implemented following the COVID-19 outbreak to stop the virus's spread. Both demand and supply-side effects on the industrial ... Read More
-
Cloud Computing in Healthcare Market by Product (Healthcare Payer Solutions, Healthcare Provider Solutions), Component (Services, Software), Pricing Model, SERVICE MODEL, Deployment Model - Global Forecast 2024-2030
... at USD 49.40 billion in 2023 and expected to reach USD 58.93 billion in 2024, at a CAGR 19.39% to reach USD 170.82 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal ... Read More
-
Spectroscopy Software Market by Deployment Mode (Cloud, On-Premise), Application (Environmental Testing, Food Testing) - Global Forecast 2024-2030
... 250.88 million in 2024, at a CAGR 11.42% to reach USD 480.44 million by 2030. Global Spectroscopy Software Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Spectroscopy Software Market. It ... Read More
-
Pharmacovigilance Market by Type (Contract Outsourcing, In-house), Clinical Trial (Phase I, Phase II, Phase III), Function, End-User - Global Forecast 2024-2030
... to reach USD 10.24 billion in 2024, at a CAGR 15.80% to reach USD 24.76 billion by 2030. Global Pharmacovigilance Market FPNV Positioning Matrix The FPNV Positioning Matrix is pivotal in evaluating the Pharmacovigilance Market. ... Read More
-
Anti-Counterfeit Pharmaceuticals & Cosmetics Packaging Market by Technology (Barcodes, Forensic Markers, Holograms), End User (Apparel & Footwear, Automotive, Cosmetics & Personal Care) - Global Forecast 2024-2030
... estimated at USD 72.52 billion in 2023 and expected to reach USD 84.18 billion in 2024, at a CAGR 16.17% to reach USD 207.08 billion by 2030. FPNV Positioning Matrix The FPNV Positioning Matrix is ... Read More
-
Medical Affairs Outsourcing Market by Services (Medical Communications, Medical Information Services, Medical Monitoring), Operational Model (Full-Service Outsourcing, Functional Outsourcing, Partial/Task-based Outsourcing), End-User - Global Forecast 2024-2030
... USD 9.78 billion in 2023 and expected to reach USD 11.16 billion in 2024, at a CAGR 14.59% to reach USD 25.39 billion by 2030. Global Medical Affairs Outsourcing MarketMedical affairs is an essential function ... Read More
-
Drug Formulation Global Market Report 2024
... Cancer; Respiratory Diseases4) By End-User: Big Pharma; Small And Medium Pharma; Biotech Companies Covering: AstraZeneca PLC; The Bristol-Myers Squibb Company; Eli Lilly and Company; Gilead Sciences Inc.; Merck & Co. Inc. Drug Formulation Global Market ... Read More
-
Global Pharmaceutical and Biopharmaceutical Safety Testing Service Market Research Report 2024(Status and Outlook)
... microbial testing, cell and molecular testing, and analytic testing. Health authorities such as the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) require all biopharmaceutical products and vaccines to undergo stringent ... Read More
-
Global Markets for Orphan Drugs
... as well as examines the regulatory framework, patents, and recent innovations in the industry. The report also analyzes each submarket and its applications, projections, and market shares. Technological issues include the latest trends and developments. ... Read More
-
2024 Global: Aerospace And Life Sciences Testing, Inspection, And Certification (Tic) Market - Innovative Markets Forecast (2030) report
... (2030) report analyzies the market size, projected growth/decline and regional data for the period 2019 through 2030. Perry/Hope Partners' reports provide the most accurate industry forecasts based on our proprietary economic models. Our forecasts project ... Read More
-
Frost Radar™: Asia-Pacific Contract Research Organizations, 2023
... witnessing the growth of small- to mid-segment pharma/biotech players making significant contributions to drug discovery and development pipelines. Across APAC, local biopharma companies are establishing themselves as key contributors to the drug development pipeline. APAC ... Read More
Research Assistance
